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Abstract
A minimum of $3.6 billion would be saved if breastfeeding were increased from
current levels (64 percent in-hospital, 29 percent at 6 months) to those recom-
mended by the U.S. Surgeon General (75 and 50 percent).  This figure is likely
an underestimation of the total savings because it represents cost savings from
the treatment of only three childhood illnesses: otitis media, gastroenteritis, and
necrotizing enterocolitis.  This report reviews breastfeeding trends and previous
studies that assessed the economic benefits of breastfeeding.








































Successfully promoting and supporting breastfeeding in the United States may
depend on persuading both mothers and society that breastfeeding is not only
nutritionally sound but economically beneficial as well.  Current U.S. rates of
breastfeeding are 64 percent for mothers in-hospital and 29 percent at 6 months
postpartum, below the recommendations of the Surgeon General (75 and 50 per-
cent, respectively).  This analysis concludes that a minimum of $3.6 billion
would be saved if the prevalence of exclusive breastfeeding increased from cur-
rent rates to those recommended by the Surgeon General. These savings would
result from reducing both direct costs (such as formula costs and physician, clin-
ic, hospital, laboratory, and procedural fees) and indirect costs (such as time and
wages lost by parents attending to an ill child).
The American Academy of Pediatrics (AAP) and the American Dietetic
Association (ADA) endorse breastfeeding as the most beneficial method to
ensure the health and well-being of most infants.  The U.S. Department of
Agriculture’s Special Supplemental Nutrition Program for Women, Infants, and
Children (WIC) has initiated a national program by Federal, State, and local
WIC programs to promote breastfeeding to WIC mothers.  This report delin-
eates that a number of studies demonstrate that breastfeeding improves infants’
general health and development and protects against a number of acute and
chronic diseases.
A number of reasons are cited for why more mothers do not breastfeed: aggres-
sive formula product marketing, lack of support from friends/family, insufficient
knowledge among medical professionals, maternity hospital practices, cultural
attitudes, and an increasing number of women in the work force.
This report reviews the few studies that have been conducted in the United
States to assess the economic benefits of breastfeeding.  Most earlier studies that
addressed this issue looked at the economic effect of breastfeeding in the con-
text of comparing breastfeeding with formula feeding, both within and outside
the WIC program.  These studies indicated that breastfeeding was economically
advantageous and that the promotion of breastfeeding could be an effective cost-
containment measure.  By and large, these studies looked at the economic effect
of breastfeeding at specific sites (State WIC clinic, local health maintenance
organization (HMO), or health clinic) and from an individual perspective.  The
analysis reported in this study goes one step further in measuring the reduced
costs to society as childhood illnesses and premature deaths are prevented.
This analysis uses incidence rates from published studies to estimate the reduc-
tion in the number of cases of otitis media, gastroenteritis, and necrotizing ente-
rocolitis that could be expected for varying prevalences of breastfeeding.  Cost
data, both direct and indirect, were derived from published literature and
extracted from U.S. Government sources.  This analysis indicated that a mini-
mum of $3.6 billion would be saved if the prevalence of exclusive breastfeeding
increased from current rates to those recommended by the Surgeon General.
This figure reflected approximately $3.1 billion attributable to preventing pre-
mature deaths (necrotizing enterocolitis), and an additional $0.5 billion in annu-
al savings associated with reducing traditional medical expenditures (for exam-
ple, doctors’ or hospital visits, laboratory tests, among others) and indirect costs,






		✥    The $3.1 billion figure probably underestimated the total savings likely because
it reflected the savings in treating only three childhood illnesses.  That figure
also excluded the cost of purchases for over-the-counter medications for otitis
media and gastroenteritis symptoms, physician charges for treatment of necro-
tizing enterocolitis, and savings due to reduced long-term morbidity.  Although
this study provided an analysis from a different perspective than previous stud-
ies, the results are consistent with those from prior investigations in demonstrat-
ing potentially substantial cost savings from breastfeeding.
Given that breastfeeding provides immunologic protection against a variety of
childhood illnesses, health care providers, corporate administrators, and State
and Federal policymakers may be able to reduce their programs’ medical costs,
over the long term, by promoting and supporting breastfeeding.  However, fur-
ther research on health and cost benefits from breastfeeding is needed, ideally,
large-scale studies for an entire range of child-related illnesses focusing on dif-
ferences in rates of hospitalization, duration of hospitalization, health service
use, and medical costs between breastfed and formula-fed infants.  Without such
studies, employers, insurance companies, and Federal health-policy decision-
makers are unlikely to provide financial incentives either to encourage breast-
feeding or to encourage health providers, such as physicians, to provide better







Breastfeeding is widely believed to be the most benefi-
cial method of feeding for the health and well-being of
most infants.1 And, although breastfeeding is not rec-
ommended for all mothers  (such as those who use
illegal drugs, receive cancer chemotherapy, or test
HIV-positive), public health experts, such as the
American Academy of Pediatrics (AAP), the American
Dietetic Association (ADA), and the Surgeon General,
endorse breastfeeding as the preferred infant-feeding
method in most cases.  More recently, the AAP issued
a policy statement recommending that infants be
breastfed throughout their first year of life (American
Academy of Pediatrics, 1997).
The U.S. Surgeon General proposed to increase the
proportion of mothers who breastfeed their babies in
the early postpartum period to 75 percent nationally by
2000, and to increase the proportion who continue
breastfeeding until their babies are 5 to 6 months old
to at least 50 percent.  According to the latest data
from Abbott Laboratories (1998), about 64 percent of
women giving birth in a hospital breastfeed, and
approximately 29 percent still breastfeed at 6 months.
Women in lower socioeconomic groups are less likely
to breastfeed and to breastfeed for a shorter time than
women in higher socioeconomic groups.  Data from a
1996 national survey, for example, indicate that only
42 percent of women from households with incomes
less than $10,000 breastfeed at all and only 12 percent
breastfeed for 6 months (Abbott Laboratories, 1996).
Breastfeeding Trends
Almost all U.S. newborns were nursed up until around
1950.  In the last 50 years, however, infant feeding has
changed markedly.  After World War II, with the devel-
opment and large-scale manufacture of infant formula,
formula feeding became the standard.  Breastfeeding
fell by half between 1946 and 1956, and by 1967, only
25 percent of American infants were being breastfed at
the time of hospital discharge.  The percentage of
infants being breastfed when they left the hospital then
began to increase steadily, reaching 62 percent in
1982, declined approximately 16 percent from 1982 to
1990, and increased slowly again to hover around 64
percent by 1998 (fig. 1).  The prevalence of breastfeed-
ing for 6-month-old infants paralleled that for new-
borns, although at a considerably lower level.  In 1998,
about 29 percent of 6-month-old infants were being
breastfed.
Mothers may refrain from breastfeeding for a number
of reasons: aggressive formula product marketing; lack
of support from family and friends; insufficient knowl-
edge among medical professionals about breastfeeding
techniques and challenges; maternity hospital practices
(short maternal stays, for example); religious beliefs;
cultural attitudes; and lack of public acceptance (Losch
et al., 1995; Weimer, 1999). All or some of these fac-
tors may come into play, but it is of interest that
increased formula feeding parallels a rapid increase in
the number of working women. Breastfeeding and
working outside the home are commonly believed to be
incompatible. A woman who works outside the home
must have a place and time to nurse her baby or express
and store her milk for bottle feeding. Increased partici-
pation of women in the labor force is frequently cited
for the low rates of breastfeeding (Cohen et al., 1995).
The increase in the number of working women since
World War II is one of the most significant social and
economic trends in modern U.S. history.  In the United
States, the number of women in the labor force
increased by 178 percent between 1950 and 1985,
while the number of men in the work force increased
by only 47 percent (U.S. Bureau of Labor Statistics,
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2&	older) worked, compared with 28 percent in 1940.  In
1995, 41 percent of the employed women had children
under the age of 18, and 55 percent of this group had
returned to the workplace before their children’s first
birthday (Hayghe, 1997).  Many workplaces seem not
to support breastfeeding or extraction of breastmilk in
the workplace, inhibiting breastfeeding after women
return to work.
Breastfeeding Health Advantages
In their endorsement of breastfeeding, entities such as
the AAP and the ADA cite studies to support the view
that breastfeeding improves infants’ general health,
growth, and development and protects against their
developing a number of acute or chronic diseases.  As
reported in a 1997 policy statement issued by the AAP,
research in the United States, Canada, Europe, and
other developed countries suggests that breastfeeding
decreases the incidence and/or severity of diarrhea
(Dewey et al., 1995; Popkin et al., 1990), lower respi-
ratory infection (Wright et al., 1989), otitis media
(Duncan et al., 1993; Owen et al., 1993), bacterial
meningitis (Cochi et al., 1986; Istre et al., 1985), botu-
lism (Arnon, 1984), urinary tract infection (Pisacane,
1992), and necrotizing enterocolitis (Lucas and Cole,
1990).  Other studies show that breastfeeding may pro-
tect against sudden infant death syndrome (Ford et al.,
1993), insulin-dependent diabetes mellitus (Gerstein,
1994; Mayer et al., 1988), Crohn’s disease (Koletzo et
al., 1989; Rigas et al., 1993), ulcerative colitis (Rigas
et al., 1993), lymphoma (Davis et al., 1988), allergic
diseases (Lucas et al., 1990; Saarinen and Kajosaari,
1995), and other chronic digestive diseases (Sveger,
1985).  According to the AAP, breastfeeding also
enhances cognitive development (Lucas et al., 1992;
Morrow-Tlucak et al., 1988; Rogan and Gladen,
1993).  A number of studies indicate possible health
benefits for mothers as well, specifically, a reduction
in hip fractures after menopause (Cumming and
Klineberg, 1993), less postpartum bleeding (Chua et
al., 1994), and  reduced risk of ovarian cancer
(Rosenblatt and Thomas, 1993) and premenopausal
breast cancer (Newcomb et al., 1994).
Some studies contradict these findings and show no
protective effect of breastfeeding, thus raising doubt
about the importance of breastfeeding to public health.
Some studies’ methodology and analytical limitations
resulted in ambiguous findings:
Lack of control of confounding factors. The groups to
be compared should match as closely as possible for
potentially confounding variables that might affect
infants’ health, such as family size, mother’s education
level, socioeconomic status, whether a parent smokes,














1970  72  74  76  78  80  82  84  86  88  90  92  94   96  98
Percent
Note:  The percentage of infants breastfed at 6 months was not measured in 1970.
Source:  Ross Laboratories Mothers’ Survey, Ross Products Division, Abbott Laboratories,1998
In hospital
6 monthsbefore the mid-1980’s did not always match groups
by these important variables.
Problems related to the definition and duration of
breastfeeding. Explicit definitions of breastfeeding
practices are important for understanding and compar-
ing studies.  Some researchers classified infants as
“breastfed” if they received any amount of breast milk
at any time.  Researchers may have called “breastfed
infants” those who were offered breast milk only once
or twice in the hospital, as well as those exclusively
breastfed for 4-6 months.  Such a mixing of groups
studied could, for example, mask any protective effects
of breastfeeding. 
Problems related to “assignment” or reverse causality.
This is a little more subtle bias, but one that can have
an important impact.  In studies of infant feeding and
health, this bias can stem from the fact that an infant’s
health can affect its feeding.  So, if the mode of feed-
ing is measured after an illness has begun, it may not
be clear, for example, whether a formula-fed infant
became ill as a result of formula feeding or whether
breastfeeding was curtailed as a result of the illness.
The illness in question, then, must be unambiguously
associated with the feeding method used just before
the onset of illness.
Economic Benefits
In addition to individual health benefits, breastfeeding
may provide significant economic benefits in terms of
defraying or reducing both direct and indirect costs.
The direct costs that might be reduced or averted
would relate, of course, to physician, clinic, hospital,
laboratory, and procedural fees.  Other direct economic
benefits to a family may be no or reduced costs to buy
infant formula for the first year after birth.  Possible
indirect costs may relate to time and wages lost by
parents (primarily mothers) attending to an ill child.
Ideally, attributing costs to time and wages lost by par-
ents attending a sick child should be considered when
estimating the possible economic benefits of breast-
feeding.  Many women return to work before a child is
1 year old (Cohen et al., 1995).  When these women
miss work, it often is because their infants are ill.  As
breastfed infants have been shown to be less likely to
catch common infectious illnesses than formula-fed
infants, it is possible that mothers who breastfeed may
miss fewer days from work to care for a sick child
than mothers who feed formula.
Previous Studies
Relatively few studies have assessed the economic
benefits of breastfeeding in the United States.  Some
earlier studies in the literature looked at the economic
effect of breastfeeding in the context of comparing
breastfeeding with formula feeding within the U.S.
Department of Agriculture’s Special Supplemental
Nutrition Program for Women, Infants, and Children
(WIC).  WIC is the largest purchaser of infant formula,
buying approximately 40 percent of all formula sold in
the United States.  The cost of infant formula distrib-
uted to WIC mothers in 1997 was $567 million after
formula company rebates of about $1.2 billion to WIC.
WIC has promoted breastfeeding, both inside and out-
side the Agency, including establishing a Breastfeeding
Promotion Consortium to exchange information and
collaborate about promoting breastfeeding.  In 1996,
the Department initiated an ongoing national campaign
by Federal, State, and local WIC programs to promote
breastfeeding to WIC mothers and to support all
women who choose to breastfeed.  However, advocates
of breastfeeding contend that if more women breast-
fed, overall WIC food costs would decrease.  A 1989
reauthorization of the WIC program, providing both a
mandate and funding, allowed States to substantially
increase breastfeeding promotion.  It should be noted
that WIC explicitly promotes breastfeeding because of
its health benefits, not because of possible reduced
food costs. 
The General Accounting Office (GAO) studied in 1993
the extent to which the WIC program promoted breast-
feeding and examined how increased breastfeeding
would affect WIC food costs for a year (U.S. GAO,
1993).  Estimating how increased breastfeeding affects
overall WIC food costs was complicated by a number
of factors, including the amount of supplemental for-
mula breastfeeding infants sometimes use, the cost of
food packages given to different participants (food
packages provided to breastfeeding women often cost
more), and the number of women served.  GAO con-
cluded that if WIC were fully funded and served all
eligible recipients, any increase in breastfeeding would
decrease total food costs, as long as formula-supple-
mented breastfed infants received no more than 25 per-
cent of the monthly amount of formula given to formu-
la-fed infants.  GAO estimated total WIC food costs
for fiscal year 1992, using 16 scenarios under varied
assumptions.  For one scenario, for example, GAO
estimated that a 10-percent increase in breastfeeding
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infants, would save the WIC program almost $408,000
per year.  If breastfed infants received 10 percent of
the formula allowed to formula-fed infants, a 10-per-
cent increase in breastfeeding rates would save the
program approximately $750,000. 
Tuttle and Dewey (1996) simulated a model of poten-
tial public cost savings for four social service pro-
grams—Medi-cal (Medicaid in California), Aid for
Families with Dependent Children (AFDC), WIC, and
Food Stamps—if breastfeeding rates increased among
Hmong (Laotian) women enrolled in WIC in
California.  Initiation of breastfeeding among Hmong
immigrants in the United States is low (about 12 per-
cent).  In this analysis, the authors estimated the cost
savings if Hmong women breastfed fully for at least 6
months.  The calculated savings were based on esti-
mates of the resulting decrease in family size, infant
morbidity, and WIC formula purchases.  The authors
used a 7½-year interval to illustrate potential cost sav-
ings over time based on the effects of changing family
size.  In part, cost calculations were based on expected
differences in fertility between breastfeeding and for-
mula-feeding women because many Asian families use
breastfeeding to space births.  Estimates of the impact
of breastfeeding on morbidity were based on two earli-
er studies that indicated breastfeeding protected
against gastrointestinal infections and otitis media
(Howie et al., 1990; Lopez et al., 1990).  Costs for
WIC were calculated using figures for voucher packets
provided to California clinics (costs included rebates
given to WIC for family vouchers redeemed at grocery
stores).  Other cost savings associated with reductions
were calculated on the basis of California Medi-Cal
reimbursement levels and standard AFDC and Food
Stamp payment rates. Costs for all four public assis-
tance programs were projected over this 7½-year peri-
od, and future values were discounted at 0, 2, and 4
percent.2 This study estimated yearly savings between
$450 and $650 (4 percent discount) and $590 and
$800 (0 percent discount) per family.  Despite self-
described limitations of this study (for example, results
were specific to Hmong immigrant population and
focused only on savings to specific public assistance
programs), this analysis provided evidence that breast-
feeding is economically advantageous.
Montgomery and Splett (1997), on the other hand,
tracked cohorts of exclusively breastfed and formula-
fed infants for 6 months in Colorado to compare WIC
costs and Medicaid expenditures.  The breastfed sam-
ple included infants breastfed exclusively for at least 3
months.  WIC costs included redeemed WIC vouchers
for formula and foods for infants and mothers, plus
administrative expenses for 6 months, minus manufac-
turers’ rebates for formula.  The benefit measure was
determined from Medicaid expenditures for health care
initiated in the first 6 months for each infant.  The
authors estimated that, compared with formula feed-
ing, breastfeeding each infant enrolled in WIC saved
$478 in WIC costs and Medicaid expenditures (1993
dollars) during the first 6 months of an infant’s life, or
$161 after consideration of the formula manufacturers’
rebate.  Although acknowledging possible incomplete
Medicaid expenditures or inconsistent or uneven
billing procedures, the authors argued that promotion
of breastfeeding among a low-income population
through nutrition programs, such as WIC, could effec-
tively contain costs.
A few studies attempted to analyze the economic
advantages of breastfeeding outside the WIC program.
Jarosz (1993) conducted a study in Hawaii to estimate,
for the first 62 days of an infant’s life, the cost of
infant formula and the cost of food a mother needs to
consume to produce breast milk.  The study assumed
that the dietary energy needs were the same in both
formula-and breast-fed infants, but that the total food
intake needed by the breastfeeding mother was 21 per-
cent greater than that needed by her baby.  Different
formula brands and food items for breastfeeding moth-
ers were surveyed and priced from a sample of stores.
Based on the author’s estimates, it would cost an extra
$45 to $70 (1991 dollars) to feed a newborn formula
for 62 days or, according to the author, two newborns
could be breastfed for the cost of one newborn who is
formula-fed.
Hoey and Ware (1997) performed a pilot study on
newborns born to mothers in a health maintenance
organization (HMO) in North Carolina.  They ana-
lyzed medical care and costs for the first 12 months
for infants that breastfed for at least 6 months and for
infants formula-fed since birth.  Medical services
included office visits, drug prescriptions, and hospital-
izations.  Although both groups of infants had similar
numbers of office visits and pharmacy costs, breastfed
infants had fewer inpatient admissions, and their total
medical costs averaged $200 less than those of formu-
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trol for demographic factors or determine the clinical
severity of each medical encounter.  This study con-
tributed to a body of evidence that points to potential
economic advantages of breastfeeding, however.
In a more comprehensive study, which estimated
national savings, Riordan (1997) calculated “addition-
al” health-care costs incurred to treat four medical
conditions if infants were not breastfed.  These four
medical conditions were infant diarrhea, respiratory
syncytial virus, insulin-dependent diabetes mellitus,
and otitis media.  For each medical condition, Riordan
garnered reported incidence rates and treatment costs,
and calculated costs avoided by breastfeeding.  Thus,
for example, Riordan indicated that 90,000 infants
were admitted to hospitals for respiratory syncytial
virus (Institute of Medicine, 1985).  Riordan pointed 
to two studies that indicated that breastfed babies were
about half as likely to be hospitalized with respiratory
syncytial virus as formula-fed babies (Okamoto and
Orgu, 1989; Pullam et al., 1980).  Citing an average
cost of $5,000 for hospitalizing an infant for this ill-
ness, and multiplying this figure by 90,000, Riordan
stated that $450 million was spent on hospitalizations
annually for this illness.  Riordan indicated that half 
of this amount, $225 million, was an “extra” cost that
could be avoided by breastfeeding.  Following this
rationale and procedure for each of the other three
medical conditions, Riordan estimated a range of $1.1
to $1.32 billion of extra health-care costs each year for
not breastfeeding.  Given that Riordan cited a dollar
amount from a different year for each medical diagno-
sis, it was not clear if this range reflected an adjust-
ment to a base year.  Riordan assumed that admission
rates reflected infants not already breastfeeding—for
example, the 90,000-infant admission figure used for
the respiratory syncytial virus estimate assumed that
none of these infants were breastfeeding but that if
they did breastfeed, only 45,000 would have been
admitted—a tenuous assumption at best.  Regardless,
Riordan indicated that these dollar estimates were con-
servative since they did not include parents’ lost work
time, were often confined only to hospital costs, and
did not include other costs associated with ill children.
In a more recent study, Ball and Wright (1999)
attempted to determine the excess cost of health care
services for three illnesses in formula-fed infants by
examining the frequency of health service use (e.g.,
office visits, hospitalizations, and prescriptions) in the
first year of life. The data were obtained from a study
conducted in Arizona that looked at the incidence of
lower respiratory illness and otitis media (Wright et al.,
1989), and a study conducted in Scotland that focused
on gastrointestinal illness among infants (Howie et al.,
1990). The authors estimated that, in the first year of
life, after adjusting for confounders, there were 2,033
excess office visits, 212 excess days of hospitalization,
and 609 excess prescriptions for these 3 illnesses per
1,000 non-breastfed infants compared with 1,000
infants exclusively breastfed for at least 3 months.
These additional services were estimated to cost
between $331 and $475 per never-breastfed infant dur-
ing the first year of life. In this study, direct medical
costs were based on the experience of a large HMO
clinic in Arizona. The authors believed that these esti-
mates of excess costs for care were conservative
because: (1) health care costs in Arizona are below the
national average, and (2) the study considered only
direct medical costs. Despite these limitations, this
study demonstrated rather substantial cost savings
expected during the first year of life.
Estimation of Benefits of
Increasing the Prevalence of 
Exclusive Breastfeeding
Despite caveats regarding methodology, all these stud-
ies contribute to a body of evidence that breastfeeding
may be economically advantageous as well as nutri-
tionally sound.  This report estimates the economic
benefits from a different perspective.  For this prelimi-
nary analysis, the economic benefits of breastfeeding
reflect the cost savings that would occur if the nation-
wide prevalence of exclusive breastfeeding, either at
hospital discharge or at 5-6 months, increased from
present levels to that recommended by the Surgeon
General.
Methodology
Given that exclusively breastfed infants have fewer ill-
nesses compared with formula-fed infants, it follows
that, as the prevalence of breastfeeding increases, the
total number of infants who become ill should decline.
The benefits of increasing the prevalence of breast-
feeding at 5-6 months, for example, from 29 to 50 per-
cent can be estimated by first calculating the number
of infants who are expected to become ill when the
prevalence of breastfeeding is 29 percent, and then cal-
culating the number of infants expected to become ill
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studies to estimate the reduced number of cases of ill-
ness that could be expected for varying prevalences of
breastfeeding for the following illnesses: otitis media,
necrotizing enterocolitis, and gastroenteritis.  Cost
data, both direct and indirect, are derived from pub-
lished literature and/or extracted from U.S.
Government sources.
Obviously, some illnesses related to infant feeding
may have major long-term impacts on quality of life—
sequelae that could increase costs significantly.
However, this analysis examines only short-term con-
siderations—benefits or costs that can be assessed by
the end of the first or second year of life when morbid-
ity rates of breastfed infants can best be compared
with those of formula-fed infants.
Otitis Media
The term “otitis media” (OM), or inflammation of the
middle ear, often is used to describe any one of a con-
tinuum of related diseases: acute otitis media, recur-
rent acute otitis media, otitis media with effusion, and
chronic otitis media with effusion.  In 1990, OM was
the most frequently reported morbidity-related princi-
pal diagnosis for children under the age of 2 years
(Scappert, 1992).  OM accounts for 20-40 percent of
office visits for children in the first 5 years (Faden et
al., 1998).  Each year, there are an estimated 30 mil-
lion visits to pediatricians to treat OM infections and
their sequelae, at an estimated cost of $1 billion.  Most
initial episodes of OM occur when a child is 6 months
old (Facione, 1990).
Duffy et al. (1997), investigating the effects of breast
and formula feeding on episodes of OM (both acute
and with effusion), found that the incidence of OM at
6 months for exclusively breastfed infants was 25 per-
cent, compared with 53 percent for formula-fed
infants.  These incidence rates can be applied to the
U.S. population to determine the number of cases of
OM that can be expected for given prevalences of
breastfeeding.  The latest birth statistics for the Nation
(U.S. Department of Health and Human Services,
2000) indicate there were 3.9 million births in 1998.
If the prevalence of exclusive breastfeeding at 6
months is 29 percent, we can expect 1,131,000 to
receive breast milk (i.e., 3.9 million x .29).  According
to Duffy, we would expect approximately 282,750
cases (1,131,000 x .25) of OM for these infants in the
first 6 months.  In this scenario, 71 percent of the new-
borns—2,769,000 infants—would receive formula.
Using Duffy’s incidence rate, we expect a total number
of OM cases for these formula-fed infants in the first 6
months to be 1,467,570 (2,769,000 x .53).  Therefore,
for a 29-percent prevalence of exclusive breastfeeding
at 6 months, we expect a total number of cases of OM
in the first 6 months to be 1,750,320 (282,750 breast-
fed, 1,467,550 formula-fed).
This same procedure may be used to calculate the
number of cases of OM that would be expected for a
50-percent prevalence of exclusive breastfeeding at 6
months.  In this case, 1,950,000 infants would be
breastfed.  Of these infants, we would expect 487,500
cases of OM (1,950,000 x .25).  We would also expect
that 1,950,000 infants would receive formula, of which
1,033,500 (1,950,000 x .53) would have an incidence
of OM.  The total number of cases of OM under this
prevalency rate (that recommended by the Surgeon
General) would be 1,521,000.  This represents a reduc-
tion of 229,320 cases from the 29-percent prevalence
rate scenario (1,750,320 – 1,521,000).
The savings due to this reduction can be calculated by
referring to published cost estimates.  The Agency for
Health Care Policy and Research (AHCPR) conducted
a cost analysis using charges recorded in a health
claims data base compiled from over 100 insurance
companies (U.S. Department of Health and Human
Services, 1994).  Indirect cost estimates were based on
time and wages lost by parents.  The AHCPR estimat-
ed an average cost per case across all treatment cate-
gories (nonsurgical and surgical) to be $1,330 (1991
dollars).  Adjusting this figure to 1998 dollars resulted
in an estimated cost of $1,592.  Applying this cost esti-
mate to the number of reduced cases of OM due to an
increase of breastfeeding prevalency at 6 months from
29 to 50 percent totals $365,077,440 ($1,592 x
229,320) in estimated savings.  Table 1 summarizes
information about the number of cases of OM and
associated costs for varying prevalences of breastfeed-
ing and formula feeding.
Gastroenteritis
Gastroenteritis, for this report, is described as vomiting
or diarrhea, or both, lasting as a discrete illness for a
24-hour period.  Diarrhea, specifically, is traditionally
defined as three or more watery or semi-watery stools
in a 24-hour period.  Gastroenteritis illness remains a
major cause of morbidity and mortality in developing






	(	01'countries.  It has been estimated that, in the United
States, 16.5 million children less than 5 years of age
have between 21 and 37 million episodes of diarrhea
annually (Glass et al., 1991).  Breastfeeding is thought
to confer some protection against diarrhea in infants
because of two likely mechanisms: (1) supplementa-
tion with formula or other food carries risk for nonhy-
gienic conditions of introducing  pathogens to an
infant’s system; and (2) breastmilk contains
immunoglobulins that increase an infant’s resistance 
to infection. 
A number of studies, for example, Howie et al. (1990)
and Dewey et al. (1995), examined the differences in
morbidity between breastfed and formula-fed infants.
Dewey found that the incidence of diarrheal illness in
the first year for exclusively breastfed infants was 14
percent, compared with 31 percent for formula-fed
babies.
Again, if the breastfeeding prevalency rate at 6 months
is 29 percent, 1,131,000 babies are breastfed, and there
would be 158,340 expected cases of diarrheal illness
among these infants (.14 x 1,131,000).  Seventy-one
percent, or 2,769,000 infants, would be formula-fed,
and there would be 858,390 expected cases of diar-
rheal illness among these infants, for a total number of
cases of diarrheal illness of 1,016,730. 
If the breastfeeding prevalence rate at 6 months were
to increase to 50 percent, 1,950,000 infants would be
breastfed, and there would be 273,000 expected cases
of diarrhea (1,950,000 x .14). For the other 50 percent,
or 1,950,000 infants that would receive formula, there
would be an expected 604,500 cases of diarrhea, for a
total case number of 877,500 under this prevalency
rate.
Increasing the breastfeeding prevalency rate at 6
months from 29 to 50 percent, then, would result in an
expected reduction of 139,230 cases of gastroenteritis
(1,016,730-877,500). Glass et al. (1991) found that 10
percent of gastroenteritis in infants prompted physician
visits, and that 1 percent led to hospitalization.  
If we assume that 10 percent of the 139,230 cases
would have led to physician visits, there would be
13,923 such visits.   Avendano et al. (1993) estimated
that an average cost per episode of diarrhea (physi-
cian’s visit) was $289 (1993 dollars).  This cost includ-
ed traditional medical expenditures (for example,
office visit, laboratory tests, etc.) as well as indirect
costs associated with parents’ missed time from work
and extra childcare due to parents’ absence from the
home.  Tucker (1998) estimated that the average hospi-
tal cost for a case of diarrhea would be $3,622, with
additional nonmedical costs (for example, forgone
earnings of parents, travel, etc.) estimated  at $100
(1996 dollars).  One percent of the 139,230 cases lead-
ing to hospitalization equates to 1,392 cases.
Converting these costs to 1998 dollars resulted in an
estimated savings for reduced physician visits of 
$4,552,821, and savings for reduced hospitalizations 
of $5,388,432, for a total savings of $9,941,253.  Table
2 shows information on the number of cases of gas-
troenteritis and associated costs for varying preva-
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Table 1   Otitis media (OM):  Number of cases and cost for various rates of breastfeeding at 6 months
29 282,750 71 1,467,570 1,750,320 2,786,509,440
40 390,000 60 1,240,200 1,630,200 2,595,278,400
50 487,500 50 1,033,500 1,521,000 2,421,432,000
60 585,000 40 826,800 1,411,800 2,247,585,600
Incidence in breastfed infants = 25 percent.
Incidence in formula-fed infants = 53 percent.
Bold-faced figures refer to examples cited in text.
Source:  Duffy et al. (1997).
Prevalence             OM cases                      Prevalence             OM cases                  OM cases                  Cost of OM
Percent                  Number                           Percent                 Number                      Number                        Dollars
Breastfed infants                                        Formula-fed infants                                             TotalsNecrotizing Enterocolitis
Necrotizing enterocolitis (NEC) is the pre-eminent
gastrointestinal tract disease encountered in the neona-
tal intensive care unit.  It is an important cause of
neonatal death and is the leading cause of emergency
surgical treatment in newborns (Neu, 1996).  Over 90
percent of NEC cases affect premature infants.
Incidence approaches 12 percent of all premature
infants with birthweight of less than 1,500 grams
(Caplan and Mackendrick, 1993).  The onset of NEC
is within the first 10 days of life in 90 percent of the
cases. Infants with NEC have various signs and symp-
toms, the most benign of which are feeding intoler-
ance, abdominal distension, and changes in stool pat-
terns.  More severe characteristics are abdominal ten-
derness, bloody stools, intestinal gangrene, bowel per-
foration, sepsis, and shock (Caplan and Mackendrick,
1993).  Lucas and Cole (1990) conducted a random-
ized controlled trial investigating the effects of breast-
feeding and formula feeding.  The incidence of NEC
in exclusively breastfed low-birthweight (LBW)
infants was 1 percent, compared with an incidence of 
7 percent in formula-fed LBW infants.  Latest statistics
indicate that 291,000 LBW infants were born in the
United States in 1997 (U.S. Department of Health and
Human Services, 1999).3
Given that the onset of NEC generally occurs within
the first month of an infant’s life, using breastfeeding
prevalency rates at 6 months to estimate potential ben-
efits is inappropriate.  Rather, the breastfeeding preva-
lency rate at hospital discharge provides a more ration-
al framework with which to gauge potential economic
benefits of this feeding mode, in terms of reducing the
number of infants who become ill.
If the prevalence of exclusive breastfeeding in the hos-
pital were currently 64 percent, then we would expect
that 186,240 infants would be breastfed, among whom
we would expect 1,862 (1 percent) cases of NEC.
Thirty-six percent or 104,760 newborns would be for-
mula-fed, and 7 percent of these, 7,733, would be
expected to contract NEC, for a total number of NEC
cases of 9,195.
At the Surgeon General’s recommended 75-percent
prevalency rate for breastfeeding in the hospital,
218,250 LBW infants would receive breastmilk with
an expected 2,182 cases (1 percent) of NEC.  Under
this scenario, 25 percent or 72,750 LBW infants would
be formula-fed and 5,092, or 7 percent, of these LBW
babies would be expected to have NEC, for a total
number of cases of 7,274.  Total reduction in the
expected number of LBW infants contracting NEC 
as a result of increased breastfeeding is 1,921 (9,195 -
7,274).  
According to Stoll (1994), 40 percent of infants who
have NEC have surgery. Data from a Government
nationwide study sample of inpatients (U.S
Department of Health and Human Services, 1996)
indicate that the average length of stay at a hospital












Prevalence             GE cases                      Prevalence                GE cases                    GE cases                    Cost of GE
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Incidence in breastfed infants = 14 percent.
Incidence in formula-fed infants = 31 percent.
Bold-faced figures refer to examples cited in text.
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!<an average cost of $118,240 (physician’s charges not
included). Assuming that 40 percent of the reduced
number of NEC cases would have had surgery (768),
savings from increased breastfeeding are estimated to
be a minimum of $90,808,320.
Additional societal costs saved from increasing the
breastfeeding rate from 64 to 75 percent relate to par-
ents’ time and lost wages.  We assume that at least one
parent would spend a minimum of 4 hours a day with
a hospitalized child during the 39-day hospital stay.
Data from the U.S. Bureau of the Census (1998) indi-
cate that 91 percent of children under 18 years of age
live in households with their mother (mother only, or
mother with another adult).  The Bureau of Labor
Statistics (1999) indicates that, for 1998, the mean
hourly earnings rate of female wage and salary work-
ers was $9.37 (ages 20-34); for men in this age range,
the mean hourly earnings rate was $10.82.  Assuming
that 91 percent of the 768 children who would require
NEC surgery would be cared for by their mother, the
resultant savings from an increased incidence of
breastfeeding is $1,021,742 (699 children x 4 hours x
39 days x $9.37).  Assuming that the remaining 9 per-
cent of the children would be attended by their fathers,
the estimated cost is $116,466 (69 children x 4 hours x
39 days x $10.82).  Total costs attributed to parents’
time and lost wages, then, is $1,138,208.
Finally, based on research from a number of investiga-
tors, for example, Stoll (1994) and Jayanthi (1998), the
NEC mortality rate (again, the third leading cause of
death in newborns) is estimated to be between 15 and
25 percent (in the first year). Valuing premature death
at $8.3 million and using the midpoint of this mortality
rate range (20 percent), the total value lost is estimated
to be $3,187,200,000.4 Total savings—hospital care,
parents’ time and wages, and deaths—are estimated to
be $3,279,146,528.  Table 3 depicts the number of
cases and associated costs of NEC for LBW infants for
varying prevalences of breastfeeding and formula feed-
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Prevalence              NEC cases                    Prevalence              NEC cases                  NEC cases              Cost of NEC
Percent                    Number                        Percent                    Number                        Number                     Dollars
Breastfed infants (LBW)                              Formula-fed infants (LBW)                                          Totals
Table 3    Necrotizing enterocolitis (NEC):  Number of cases and costs for various rates of breastfeeding
for low birth weight infants (LBW) at hospital discharge
64 1,862 36 7,333 9,195   15,704,037,798
70 2,037 30 6,111 8,148 13,919,174,183
75 2,182 25 5,092 7,274 12,424,891,270
80 2,328 20 4,074 6,402 10,930,608,131
Incidence in breastfed infants = 1 percent.
Incidence in formula-fed infants = 7 percent.
Bold-faced figures refer to examples cited in text.















































































Federal and public-health policies promote breastfeed-
ing because breastfed infants are healthier.  Economics
can identify the economic consequences of increased
breastfeeding by measuring the reduction in medical
and other costs associated with having healthier
babies.  Many prior studies looked at the cost-effec-
tiveness of breastfeeding from the individual’s per-
spective.  This study goes one step further to measure
reduced costs to society as childhood illnesses and pre-
mature deaths are prevented.
This preliminary analysis of breastfeeding and formula
feeding indicates that a minimum of $3.6 billion would
be saved if the prevalence of exclusive breastfeeding
increased from current rates (64 percent in-hospital, 29
percent at 6 months) to those recommended by the
Surgeon General (75 and 50 percent, respectively).
This figure reflects approximately $3.1 billion attribut-
able to preventing premature deaths, and an additional
$0.5 billion annual savings associated with reducing
traditional medical expenditures (for example, office or
hospital visits, laboratory tests, etc.) and indirect costs
such as forgone earnings of parents, among others. 
This figure probably underestimates the total savings
likely.  This figure represents only cost savings due 
to reduced costs to treat three childhood illness; it
excludes the cost of purchases for over-the-counter
medications for treatment of OM and gastroenteritis
symptoms, physician charges related to the treatment
of NEC, and cost savings due to reductions in long-
term morbidity.
Although this analysis provided a perspective different
from that found in previous studies, the results from
this study are consistent with those from prior investi-
gations in demonstrating that the potential for cost sav-
ings from breastfeeding is substantial.  Costs of med-
ical care continue upward.  The Nation’s total spend-
ing for health care in 1995 was nearly $1 trillion
($988.5 billion), an increase of 5.5 percent from the
previous year, reflecting an estimated average of
$3,621 per person.  This figure represents 13.6 percent
of the gross domestic product, a percentage approxi-
mately double that of any other developed nation (U.S.
Department of Health and Human Services, 1997).
Breastfeeding involves mostly primary and, to a lesser
extent, secondary prevention.  Primary prevention is
any activity that prevents a disease from ever starting.
Secondary prevention is any activity that cures or
reduces the severity of a disease.  As described in the
introduction, the literature indicates that breastfeeding
provides primary and some secondary protection
against viral, bacterial, and allergic diseases.  The U.S.
Department of Health and Human Services’Agency
for Health Care Policy and Research (AHCPR) or
other Federal cost-control deliberations do not include
breastfeeding, however. 
Given that breastfeeding does provide immunologic
protection against a variety of illnesses, health-care
providers, corporate administrators, and State or
Federal policymakers could see a decline in their costs
for pediatric care with an increase in breastfeeding.
Since managed-care plans emphasize the rewards for
preventing health problems and not using health serv-
ices, their support for breastfeeding may be a cost-
effective way to keep insured clients healthy.
Undoubtedly, further research on health and cost bene-
fits of breastfeeding is needed.  Ideally, for an entire
range of child-related illnesses, large-scale research
studies should specifically focus on rates of hospital-
ization, duration of hospitalization, health-service use,
and medical costs among breastfed and formula-fed
infants.  Much of the current available data are based
on studies in specific locales (for example, clinics or
local hospitals).  Some data are available from large-
scale epidemiological research.  However, as Riordan
(1997) pointed out, there are problems conducting epi-
demiological research on breastfeeding in this country,
which lacks a central data source for infant morbidity
and mortality.  She notes, for example, that the only
purportedly reliable data about breastfeeding rates are
from an infant formula company.  The Federal
Government (the Centers for Disease Control and
Prevention, for example) publishes data about selected
childhood diagnoses, but much of the reported data are
categorized according to age groups (usually 0-15
years) that do not separate out the first or second year
of life—years when breastfed infant morbidity can






	(	01'The data used in this report reflect estimates garnered
from incidence rates, treatment costs, and calculated
potential savings generated by breastfeeding based on
disparate, sometimes local sources.  The beneficial
effects of breastfeeding are likely greater than those
shown here and in other studies.  Given these caveats,
however, without such health and cost benefit studies,
employers, insurance companies and Federal health
policymakers are unlikely to provide financial incen-
tives either to encourage breastfeeding or to encourage
health care providers (including physicians) to provide
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